Letter to the editor, Reply to: Lee and Matulonis: Immunotherapy and radiation combinatorial trials in gynecologic cancer: A potential synergy?

•CALLA (NCT03830866) is a randomized, international, double-blind, placebo-controlled study.•Immunotherapy-naïve patients with adenocarcinoma or cervical carcinoma are being enrolled.•CALLA is one of the largest trials in this patient population.

Saved in:
Bibliographic Details
Published in:Gynecologic oncology reports 2019-11, Vol.30, p.100506-100506, Article 100506
Main Authors: Monk, Bradley J., Mayadev, Jyoti, Nunes, Ana T.
Format: Article
Language:English
Subjects:
Correspondence
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:•CALLA (NCT03830866) is a randomized, international, double-blind, placebo-controlled study.•Immunotherapy-naïve patients with adenocarcinoma or cervical carcinoma are being enrolled.•CALLA is one of the largest trials in this patient population.
ISSN:2352-5789
2352-5789
DOI:10.1016/j.gore.2019.100506